PV Watch Daily
  • Home
  • Inspections & Compliance
  • AI & Digital PV
  • Careers
  • Regulatory Updates
  • Safety Signals
  • Explainers
  • News
  • About
Select Page
MHRA Strengthens Warnings for Gabapentinoids, Benzodiazepines and Z-Drugs

MHRA Strengthens Warnings for Gabapentinoids, Benzodiazepines and Z-Drugs

by Admin | Mar 14, 2026 | Inspections & Compliance

MHRA has reviewed how risk information is communicated for gabapentinoids, benzodiazepines, and z-drugs and concluded that warnings on these medicines need to be strengthened. The agency said it was necessary to improve the warnings regarding addiction, dependence,...
FDA Warning Letter to Novo Nordisk: What the March 2026 Action Signals for PV Compliance

FDA Warning Letter to Novo Nordisk: What the March 2026 Action Signals for PV Compliance

by Admin | Mar 13, 2026 | Inspections & Compliance

On 5 March 2026, the FDA issued a warning letter to Novo Nordisk Inc. describing objectionable conditions observed during an inspection that reviewed the company’s compliance with postmarketing adverse drug experience (PADE) regulations. According to the letter, the...
Next Entries »

Recent Posts

  • Why Regulators Are Building Always-On Safety Information Hubs
  • CVMP March 2026 Highlights Keep Veterinary Safety in View
  • EMA’s ESMP Training Push Signals More Structured Shortage Reporting
  • EMA Adds Anktiva to Additional Monitoring List in March 2026
  • Rabies Immunoglobulin Recall Follows Potency Stability Failure

Recent Comments

No comments to show.

PV Watch Daily

PV Watch Daily is a specialist news and intelligence platform covering pharmacovigilance, drug safety, regulatory updates, safety signals, inspections, AI in PV, compliance trends, and career developments across the global life sciences industry.

Quick Links

Home
Latest News
About
Contact
Newsletter
Editorial Policy

Categories

Regulatory Updates
Safety Signals
AI & Digital PV
Inspections & Compliance
Explainers
Careers
News

Get the Daily PV Brief

Subscribe for timely drug safety news, pharmacovigilance updates, safety alerts, and regulatory intelligence delivered to your inbox.

Subscribe Free

For inquiries: editor@pvwatchdaily.com

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
►
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None
Powered by